Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INVION LIMITED Director's Dealing 2015

Apr 27, 2015

65148_rns_2015-04-27_ab0af437-c822-4b63-923c-a9d40efb94b6.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity INVION LIMITED ABN 76 094 730 417

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director DR GREG COLLIER
Date of last notice 27 November 2014

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevant Barwon Biotechnology Pty Ltd of whichDr Collier is a director and shareholder.
interest.
Beacon Super Fund Pty Ltd ATF Beacon
Super Fund of which Dr Collier is a director
and beneficiary.
Date of change 24 April 2015
No. of securities held prior to change 15,761,352 fully paid Ordinary Shares
10,000,000 Share Options with an exercise
price of $0.10 and an expiry date of
9 November 2017.
Class Fully paid ordinary shares
Number acquired 264,286 fully paid Ordinary Shares
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed nil
Value/Consideration $0.025 per share acquired
Note: If consideration is non-cash, provide details and estimated
valuation
No. of securities held after change 16,025,638 fully paid Ordinary Shares
10,000,000 Share Options with an exercise
price of $0.10 and an expiry date of
9 November 2017.
Nature of change Issue of securities further to participation as
Example: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participation inbuy-back an eligible shareholder under the Company’sRightsIssueEntitlementOfferdated
20March 2015.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract n/a
Nature of interest n/a
Name of registered holder n/a
(if issued securities)
Date of change n/a
No. and class of securities to which n/a
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired n/a
Interest disposed n/a
Value/Consideration n/a
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change n/a
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed No. above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade n/a to proceed during this period? If prior written clearance was provided, on what date was this n/a provided?

  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3